Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience

Jared R. Robbins, Matthew J. Krasin, Atmaram S. Pai Panandiker, Amy Watkins, Jianrong Wu, Victor M. Santana, Wayne L. Furman, Andrew M. Davidoff, Lisa M. McGregor

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Purpose: The purpose of the study was to compare outcomes of pediatric patients with high-risk metastatic neuroblastoma who received radiotherapy (RT) with those of patients who did not. Patients and methods: We reviewed the records of 63 patients with newly diagnosed metastatic neuroblastoma treated at our institution (1989-2001) to investigate their characteristics at presentation, dose and field of RT, treatment response, and failure patterns. Results: Seventeen patients received RT, and 46 did not. In the RT group, a greater percentage of patients had residual disease before consolidation than did those in the no-RT group (88.2% vs 69.6%, P = .008). Gross total resection was achieved less often in the RT group (65% vs 89%, P = .055), but the 5-year cumulative incidences of local failure were similar (35.3% ± 12.4% vs 32.6% ± 7.1%). Although there was no difference in 5-year event-free survival, overall survival was better in the no-RT group (47.8% ± 7.2% vs 23.5% ± 9.2%, P = .026). Conclusion: The addition of RT to the therapy of a group of patients with more residual locoregional disease appeared to improve the local failure rate to approximately that of patients with less residual disease. Radiotherapy may provide even greater benefit to those with less residual disease before consolidation.

Original languageEnglish (US)
Pages (from-to)678-686
Number of pages9
JournalJournal of pediatric surgery
Volume45
Issue number4
DOIs
StatePublished - Apr 1 2010

Fingerprint

Neuroblastoma
Radiotherapy
Research
Group Psychotherapy
Treatment Failure
Disease-Free Survival
Pediatrics
Survival
Incidence

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Robbins, Jared R. ; Krasin, Matthew J. ; Pai Panandiker, Atmaram S. ; Watkins, Amy ; Wu, Jianrong ; Santana, Victor M. ; Furman, Wayne L. ; Davidoff, Andrew M. ; McGregor, Lisa M. / Radiation therapy as part of local control of metastatic neuroblastoma : the St Jude Children's Research Hospital experience. In: Journal of pediatric surgery. 2010 ; Vol. 45, No. 4. pp. 678-686.
@article{a416422861a7494db60a79460ca7fbf1,
title = "Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience",
abstract = "Purpose: The purpose of the study was to compare outcomes of pediatric patients with high-risk metastatic neuroblastoma who received radiotherapy (RT) with those of patients who did not. Patients and methods: We reviewed the records of 63 patients with newly diagnosed metastatic neuroblastoma treated at our institution (1989-2001) to investigate their characteristics at presentation, dose and field of RT, treatment response, and failure patterns. Results: Seventeen patients received RT, and 46 did not. In the RT group, a greater percentage of patients had residual disease before consolidation than did those in the no-RT group (88.2{\%} vs 69.6{\%}, P = .008). Gross total resection was achieved less often in the RT group (65{\%} vs 89{\%}, P = .055), but the 5-year cumulative incidences of local failure were similar (35.3{\%} ± 12.4{\%} vs 32.6{\%} ± 7.1{\%}). Although there was no difference in 5-year event-free survival, overall survival was better in the no-RT group (47.8{\%} ± 7.2{\%} vs 23.5{\%} ± 9.2{\%}, P = .026). Conclusion: The addition of RT to the therapy of a group of patients with more residual locoregional disease appeared to improve the local failure rate to approximately that of patients with less residual disease. Radiotherapy may provide even greater benefit to those with less residual disease before consolidation.",
author = "Robbins, {Jared R.} and Krasin, {Matthew J.} and {Pai Panandiker}, {Atmaram S.} and Amy Watkins and Jianrong Wu and Santana, {Victor M.} and Furman, {Wayne L.} and Davidoff, {Andrew M.} and McGregor, {Lisa M.}",
year = "2010",
month = "4",
day = "1",
doi = "10.1016/j.jpedsurg.2009.11.003",
language = "English (US)",
volume = "45",
pages = "678--686",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "4",

}

Robbins, JR, Krasin, MJ, Pai Panandiker, AS, Watkins, A, Wu, J, Santana, VM, Furman, WL, Davidoff, AM & McGregor, LM 2010, 'Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience', Journal of pediatric surgery, vol. 45, no. 4, pp. 678-686. https://doi.org/10.1016/j.jpedsurg.2009.11.003

Radiation therapy as part of local control of metastatic neuroblastoma : the St Jude Children's Research Hospital experience. / Robbins, Jared R.; Krasin, Matthew J.; Pai Panandiker, Atmaram S.; Watkins, Amy; Wu, Jianrong; Santana, Victor M.; Furman, Wayne L.; Davidoff, Andrew M.; McGregor, Lisa M.

In: Journal of pediatric surgery, Vol. 45, No. 4, 01.04.2010, p. 678-686.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Radiation therapy as part of local control of metastatic neuroblastoma

T2 - the St Jude Children's Research Hospital experience

AU - Robbins, Jared R.

AU - Krasin, Matthew J.

AU - Pai Panandiker, Atmaram S.

AU - Watkins, Amy

AU - Wu, Jianrong

AU - Santana, Victor M.

AU - Furman, Wayne L.

AU - Davidoff, Andrew M.

AU - McGregor, Lisa M.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Purpose: The purpose of the study was to compare outcomes of pediatric patients with high-risk metastatic neuroblastoma who received radiotherapy (RT) with those of patients who did not. Patients and methods: We reviewed the records of 63 patients with newly diagnosed metastatic neuroblastoma treated at our institution (1989-2001) to investigate their characteristics at presentation, dose and field of RT, treatment response, and failure patterns. Results: Seventeen patients received RT, and 46 did not. In the RT group, a greater percentage of patients had residual disease before consolidation than did those in the no-RT group (88.2% vs 69.6%, P = .008). Gross total resection was achieved less often in the RT group (65% vs 89%, P = .055), but the 5-year cumulative incidences of local failure were similar (35.3% ± 12.4% vs 32.6% ± 7.1%). Although there was no difference in 5-year event-free survival, overall survival was better in the no-RT group (47.8% ± 7.2% vs 23.5% ± 9.2%, P = .026). Conclusion: The addition of RT to the therapy of a group of patients with more residual locoregional disease appeared to improve the local failure rate to approximately that of patients with less residual disease. Radiotherapy may provide even greater benefit to those with less residual disease before consolidation.

AB - Purpose: The purpose of the study was to compare outcomes of pediatric patients with high-risk metastatic neuroblastoma who received radiotherapy (RT) with those of patients who did not. Patients and methods: We reviewed the records of 63 patients with newly diagnosed metastatic neuroblastoma treated at our institution (1989-2001) to investigate their characteristics at presentation, dose and field of RT, treatment response, and failure patterns. Results: Seventeen patients received RT, and 46 did not. In the RT group, a greater percentage of patients had residual disease before consolidation than did those in the no-RT group (88.2% vs 69.6%, P = .008). Gross total resection was achieved less often in the RT group (65% vs 89%, P = .055), but the 5-year cumulative incidences of local failure were similar (35.3% ± 12.4% vs 32.6% ± 7.1%). Although there was no difference in 5-year event-free survival, overall survival was better in the no-RT group (47.8% ± 7.2% vs 23.5% ± 9.2%, P = .026). Conclusion: The addition of RT to the therapy of a group of patients with more residual locoregional disease appeared to improve the local failure rate to approximately that of patients with less residual disease. Radiotherapy may provide even greater benefit to those with less residual disease before consolidation.

UR - http://www.scopus.com/inward/record.url?scp=77950471784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950471784&partnerID=8YFLogxK

U2 - 10.1016/j.jpedsurg.2009.11.003

DO - 10.1016/j.jpedsurg.2009.11.003

M3 - Article

C2 - 20385270

AN - SCOPUS:77950471784

VL - 45

SP - 678

EP - 686

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 4

ER -